SG10201802811PA - Sense-antisense gene pairs for patient stratification, prognosis, and therapeutic biomarkers identification - Google Patents

Sense-antisense gene pairs for patient stratification, prognosis, and therapeutic biomarkers identification

Info

Publication number
SG10201802811PA
SG10201802811PA SG10201802811PA SG10201802811PA SG10201802811PA SG 10201802811P A SG10201802811P A SG 10201802811PA SG 10201802811P A SG10201802811P A SG 10201802811PA SG 10201802811P A SG10201802811P A SG 10201802811PA SG 10201802811P A SG10201802811P A SG 10201802811PA
Authority
SG
Singapore
Prior art keywords
prognosis
sense
gene pairs
antisense gene
patient stratification
Prior art date
Application number
SG10201802811PA
Inventor
Oleg Grinchuk
Efthimios Motakis
Surya Pavan Yenamandra
Vladimir Andreevich Kuznetsov
Original Assignee
Agency Science Tech & Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agency Science Tech & Res filed Critical Agency Science Tech & Res
Publication of SG10201802811PA publication Critical patent/SG10201802811PA/en

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B35/00—ICT specially adapted for in silico combinatorial libraries of nucleic acids, proteins or peptides
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20—Supervised data analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
    • G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
    • G16C20/60—In silico combinatorial chemistry
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
SG10201802811PA 2013-10-18 2014-10-20 Sense-antisense gene pairs for patient stratification, prognosis, and therapeutic biomarkers identification SG10201802811PA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SG2013079173A SG2013079173A (en) 2013-10-18 2013-10-18 Sense-antisense gene pairs for patient stratification, prognosis, and therapeutic biomarkers identification

Publications (1)

Publication Number Publication Date
SG10201802811PA true SG10201802811PA (en) 2018-05-30

Family

ID=52828476

Family Applications (3)

Application Number Title Priority Date Filing Date
SG2013079173A SG2013079173A (en) 2013-10-18 2013-10-18 Sense-antisense gene pairs for patient stratification, prognosis, and therapeutic biomarkers identification
SG10201802811PA SG10201802811PA (en) 2013-10-18 2014-10-20 Sense-antisense gene pairs for patient stratification, prognosis, and therapeutic biomarkers identification
SG11201603013XA SG11201603013XA (en) 2013-10-18 2014-10-20 Sense-antisense gene pairs for patient stratification, prognosis, and therapeutic biomarkers identification

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG2013079173A SG2013079173A (en) 2013-10-18 2013-10-18 Sense-antisense gene pairs for patient stratification, prognosis, and therapeutic biomarkers identification

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG11201603013XA SG11201603013XA (en) 2013-10-18 2014-10-20 Sense-antisense gene pairs for patient stratification, prognosis, and therapeutic biomarkers identification

Country Status (4)

Country Link
US (1) US20160259883A1 (en)
EP (1) EP3058097A4 (en)
SG (3) SG2013079173A (en)
WO (1) WO2015057169A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11568982B1 (en) 2014-02-17 2023-01-31 Health at Scale Corporation System to improve the logistics of clinical care by selectively matching patients to providers
WO2015189264A1 (en) * 2014-06-10 2015-12-17 Ventana Medical Systems, Inc. Predicting breast cancer recurrence directly from image features computed from digitized immunohistopathology tissue slides
CN105809271A (en) * 2016-01-13 2016-07-27 中国林业科学研究院林业研究所 Biomass model estimation method based on combined prediction method
CN106202969B (en) * 2016-08-01 2018-10-23 东北大学 A kind of tumor cells parting forecasting system
CN111321221B (en) * 2018-12-14 2022-09-23 中国医学科学院肿瘤医院 Composition, microarray and computer system for predicting risk of recurrence after regional resection of rectal cancer
EP3935581A4 (en) 2019-03-04 2022-11-30 Iocurrents, Inc. Data compression and communication using machine learning
US11610679B1 (en) 2020-04-20 2023-03-21 Health at Scale Corporation Prediction and prevention of medical events using machine-learning algorithms
CN112802546B (en) * 2020-12-29 2024-05-03 中国人民解放军军事科学院军事医学研究院 Biological state characterization method, device, equipment and storage medium
CN112746108B (en) * 2021-01-11 2022-04-05 中国医学科学院肿瘤医院 Gene marker for tumor prognosis hierarchical evaluation, evaluation method and application
CN113736879B (en) * 2021-09-03 2023-09-22 中国医学科学院肿瘤医院 System for prognosis of small cell lung cancer patient and application thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5435609B2 (en) * 2007-05-31 2014-03-05 独立行政法人理化学研究所 Novel cancer marker and its use
US20120117018A1 (en) * 2009-03-10 2012-05-10 Agency For Science, Technology And Research Method for the systematic evaluation of the prognostic properties of gene pairs of medical conditions, and certain gene pairs identified
US20110320390A1 (en) * 2009-03-10 2011-12-29 Kuznetsov Vladimir A Method for identification, prediction and prognosis of cancer aggressiveness

Also Published As

Publication number Publication date
EP3058097A1 (en) 2016-08-24
SG11201603013XA (en) 2016-05-30
US20160259883A1 (en) 2016-09-08
SG2013079173A (en) 2015-05-28
WO2015057169A1 (en) 2015-04-23
EP3058097A4 (en) 2017-11-01

Similar Documents

Publication Publication Date Title
SG11201603013XA (en) Sense-antisense gene pairs for patient stratification, prognosis, and therapeutic biomarkers identification
HK1221908A1 (en) Polyspecificity reagents, methods for their preparation and use (polyspecificity)
HRP20182063T1 (en) Rhizomania-resistant gene
HK1209800A1 (en) Method and kit for non-invasively detecting egfr gene mutaions egfr
EP2972308A4 (en) Biomarkers and methods for predicting preterm birth
EP2847593A4 (en) Methods for predicting and detecting cancer risk
ZA201507315B (en) Selective gene therapy expression system
EP2972393A4 (en) Biomarkers and methods for predicting preeclampsia
EP2971132A4 (en) Tissue and blood-based mirna biomarkers for the diagnosis, prognosis and metastasis-predictive potential in colorectal cancer
SG11201508544VA (en) Genetic marker for early breast cancer prognosis prediction and diagnosis, and use thereof
GB2513771B (en) Biomarkers for breast cancer predictions and diagnoses
EP2888370A4 (en) Methods for diagnosis, prognosis and methods of treatment
HK1207887A1 (en) Assays, methods and apparatus for assessing rna disruption rna
SG11201602291TA (en) Nucleic acid biomarker and use thereof
HK1205558A1 (en) Methods and biomarkers for detection and prognosis of cervical cancer
EP3800259C0 (en) Axmi486 toxin gene and methods for its use
SG11201510209SA (en) Cell populations, methods of transdifferention and methods of use thereof
SG10201700984PA (en) Probe card case and probe card transfer method
IL253967B (en) Herbicide-resistant protein, encoding gene and use thereof
EP2803726A4 (en) Standardized reference gene for microrna and use thereof
EP2958999A4 (en) Gene signatures for lung cancer prognosis and therapy selection
ZA201705395B (en) Herbicide-resistant protein, encoding gene and use thereof
EP2802648A4 (en) Cancer-specific suicide gene for cell-based and gene therapy
EP2943794A4 (en) Biomarkers in cancer, methods, and systems related thereto
EP3052943A4 (en) Biomarkers for cell therapy